Neurotrack
Delaware corporation · 2 known investors
Neurotrack provides remote cognitive assessment tools for clinicians to detect early cognitive decline through eye-tracking technology, enabling earlier intervention for patients at risk of Alzheimer's and cognitive conditions. The company serves health systems, health plans, and clinical providers seeking to screen for mild cognitive impairment before symptom progression.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Founders & leadership
EK
Elli KaplanCo-founder & CEO
DS

Dr. Stuart ZolaScientific Co-founder
DE

Dr. Elizabeth BuffaloScientific Co-founder
CM
Cecelia ManzanaresCo-founder
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$21.1MraisedJun 2019 · 7 investors · Other Health CareRule 506(b)
▶$21.1MraisedJun 2019 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elli KaplanExecutive Officer, Director
- Phil WickhamDirector
- Samir KaulDirector
- Cheryl ScottDirector
- Offering amount
- $21.1M
- Amount sold
- $21.1M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.9MraisedMay 2017 · 11 investors · Other Health CareRule 506(b)
▶$9.9MraisedMay 2017 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elli KaplanExecutive Officer, Director, Promoter
- Elli KaplanDirector
- Elli KaplanDirector
- Offering amount
- $10.9M
- Amount sold
- $9.9M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.